Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
ACS Medicinal Chemistry Letters
|
June 6, 2014
β-Lactones Inhibit N-acylethanolamine Acid Amidase by S-Acylation of the Catalytic N-Terminal Cysteine
Andrea Armirotti, Elisa Romeo, Stefano Ponzano, et al.
Journal of Medicinal Chemistry
|
October 28, 2009
Synthesis, structure-activity relationships, and characterization of novel nonsteroidal and selective androgen receptor modulators
Nathalie Schlienger, Birgitte W Lund, Jan Pawlas, et al.
Journal of Medicinal Chemistry
|
September 3, 2013
Synthesis and structure-activity relationship (SAR) of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters, a class of potent N-acylethanolamine acid amidase (NAAA) inhibitors
Stefano Ponzano, Fabio Bertozzi, Luisa Mengatto, et al.
Science Advances
|
March 5, 2020
Discovery of a picomolar potency pharmacological corrector of the mutant CFTR chloride channel
Nicoletta Pedemonte, Fabio Bertozzi, Emanuela Caci, et al.
International Journal of Molecular Sciences
|
June 2, 2021
Partial Rescue of F508del-CFTR Stability and Trafficking Defects by Double Corrector Treatment
Valeria Capurro, Valeria Tomati, Elvira Sondo, et al.
ACS Chemical Biology
|
April 16, 2015
A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation
Alison Ribeiro, Silvia Pontis, Luisa Mengatto, et al.
Journal of Medicinal Chemistry
|
September 18, 2020
Identification, Structure-Activity Relationship, and Biological Characterization of 2,3,4,5-Tetrahydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indoles as a Novel Class of CFTR Potentiators
Nicoletta Brindani, Ambra Gianotti, Simone Giovani, et al.
Cancer Drug Resistance (Alhambra, Calif.)
|
October 23, 2025
Molecular targeting of the deubiquitinase USP14 to circumvent cisplatin resistance in ovarian carcinoma and identification of novel inhibitors
Cristina Corno, Debora Russo, Francesco Pignotti, et al.
Journal of Medicinal Chemistry
|
September 1, 2021
Discovery and SAR Evolution of Pyrazole Azabicyclo[3.2.1]octane Sulfonamides as a Novel Class of Non-Covalent <i>N</i>-Acylethanolamine-Hydrolyzing Acid Amidase (NAAA) Inhibitors for Oral Administration
Paolo Di Fruscia, Anna Carbone, Giovanni Bottegoni, et al.
Brain : a Journal of Neurology
|
July 15, 2025
Oxytocin seals the blood-brain barrier, improving 22q11.2 deletion syndrome trajectories
Giulia Castellani, Mariasole Ciampoli, Arianna Benedetti, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
ACS Medicinal Chemistry Letters
|
June 6, 2014
β-Lactones Inhibit N-acylethanolamine Acid Amidase by S-Acylation of the Catalytic N-Terminal Cysteine
Andrea Armirotti, Elisa Romeo, Stefano Ponzano, et al.
Journal of Medicinal Chemistry
|
October 28, 2009
Synthesis, structure-activity relationships, and characterization of novel nonsteroidal and selective androgen receptor modulators
Nathalie Schlienger, Birgitte W Lund, Jan Pawlas, et al.
Journal of Medicinal Chemistry
|
September 3, 2013
Synthesis and structure-activity relationship (SAR) of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters, a class of potent N-acylethanolamine acid amidase (NAAA) inhibitors
Stefano Ponzano, Fabio Bertozzi, Luisa Mengatto, et al.
Science Advances
|
March 5, 2020
Discovery of a picomolar potency pharmacological corrector of the mutant CFTR chloride channel
Nicoletta Pedemonte, Fabio Bertozzi, Emanuela Caci, et al.
International Journal of Molecular Sciences
|
June 2, 2021
Partial Rescue of F508del-CFTR Stability and Trafficking Defects by Double Corrector Treatment
Valeria Capurro, Valeria Tomati, Elvira Sondo, et al.
ACS Chemical Biology
|
April 16, 2015
A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation
Alison Ribeiro, Silvia Pontis, Luisa Mengatto, et al.
Journal of Medicinal Chemistry
|
September 18, 2020
Identification, Structure-Activity Relationship, and Biological Characterization of 2,3,4,5-Tetrahydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indoles as a Novel Class of CFTR Potentiators
Nicoletta Brindani, Ambra Gianotti, Simone Giovani, et al.
Cancer Drug Resistance (Alhambra, Calif.)
|
October 23, 2025
Molecular targeting of the deubiquitinase USP14 to circumvent cisplatin resistance in ovarian carcinoma and identification of novel inhibitors
Cristina Corno, Debora Russo, Francesco Pignotti, et al.
Journal of Medicinal Chemistry
|
September 1, 2021
Discovery and SAR Evolution of Pyrazole Azabicyclo[3.2.1]octane Sulfonamides as a Novel Class of Non-Covalent <i>N</i>-Acylethanolamine-Hydrolyzing Acid Amidase (NAAA) Inhibitors for Oral Administration
Paolo Di Fruscia, Anna Carbone, Giovanni Bottegoni, et al.
Brain : a Journal of Neurology
|
July 15, 2025
Oxytocin seals the blood-brain barrier, improving 22q11.2 deletion syndrome trajectories
Giulia Castellani, Mariasole Ciampoli, Arianna Benedetti, et al.
Page
of 4